Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
BT-20 | NVP-TAE684 | 0.0016596 | uM | 4 | 1250.00 | 665.42 | 2167.00 | 2047.25 | 1.0585 | 1.0714 |
BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 2351.00 | 2047.25 | 1.1484 | 1.1781 | |
BT-20 | NVP-TAE684 | 10 | uM | 4 | 1250.00 | 665.42 | 516.00 | 2047.25 | 0.2521 | -0.1452 |
BT-20 | Nilotinib | 0.0033113 | uM | 4 | 1250.00 | 665.42 | 2255.00 | 2047.25 | 1.1015 | 1.1228 |
BT-20 | NVP-TAE684 | 0.0033113 | uM | 4 | 1250.00 | 665.42 | 2402.00 | 2047.25 | 1.1733 | 1.2072 |
BT-20 | Nilotinib | 0.31623 | uM | 4 | 1250.00 | 665.42 | 2423.00 | 2047.25 | 1.1835 | 1.2190 |
BT-20 | PLX-4720 | 3.1623 | uM | 4 | 1250.00 | 665.42 | 2052.00 | 2047.25 | 1.0023 | 1.0029 |
BT-20 | NVP-TAE684 | 1 | uM | 4 | 1250.00 | 665.42 | 2071.00 | 2047.25 | 1.0116 | 1.0143 |
BT-20 | Etoposide | 0.1 | uM | 4 | 1250.00 | 665.42 | 2123.00 | 2047.25 | 1.0370 | 1.0453 |
BT-20 | Nilotinib | 0.031623 | uM | 4 | 1250.00 | 665.42 | 2476.00 | 2047.25 | 1.2094 | 1.2489 |
BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 2431.00 | 2047.25 | 1.1874 | 1.2236 | |
BT-20 | PLX-4720 | 19.9526 | uM | 4 | 1250.00 | 665.42 | 1648.00 | 2047.25 | 0.8050 | 0.7495 |
BT-20 | NVP-TAE684 | 0.31623 | uM | 4 | 1250.00 | 665.42 | 2022.00 | 2047.25 | 0.9877 | 0.9848 |
BT-20 | Nilotinib | 1 | uM | 4 | 1250.00 | 665.42 | 2347.00 | 2047.25 | 1.1464 | 1.1759 |
BT-20 | PLX-4720 | 0.31623 | uM | 4 | 1250.00 | 665.42 | 2639.00 | 2047.25 | 1.2890 | 1.3391 |
BT-20 | PLX-4720 | 0.01 | uM | 4 | 1250.00 | 665.42 | 2289.00 | 2047.25 | 1.1181 | 1.1425 |
BT-20 | Etoposide | 0.031623 | uM | 4 | 1250.00 | 665.42 | 2395.00 | 2047.25 | 1.1699 | 1.2032 |
BT-20 | Nilotinib | 3.1623 | uM | 4 | 1250.00 | 665.42 | 2262.00 | 2047.25 | 1.1049 | 1.1269 |
BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 2013.00 | 2047.25 | 0.9833 | 0.9793 | |
BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 1965.00 | 2047.25 | 0.9598 | 0.9501 | |
BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 1625.00 | 2047.25 | 0.7938 | 0.7344 | |
BT-20 | 0 | uM | 4 | 2500.00 | 1354.79 | 3194.00 | 4475.25 | 0.7137 | 0.6446 | |
BT-20 | 0 | uM | 4 | 2500.00 | 1354.79 | 3703.00 | 4475.25 | 0.8274 | 0.7919 | |
BT-20 | Etoposide | 10 | uM | 4 | 2500.00 | 1354.79 | 1160.00 | 4475.25 | 0.2592 | -0.0861 |
BT-20 | PLX-4720 | 0.031623 | uM | 4 | 2500.00 | 1354.79 | 4674.00 | 4475.25 | 1.0444 | 1.0511 |